Choroid Plexus Carcinoma

• CLINICAL_TRIALS trial_result · 2026-06-08
  Clinical Trial Results: Intra-Arterial Chemotherapy for Newly Diagnosed, Residual, or Recurrent Atypical Choroid Plexus Papilloma and Choroid Plexus Carcinoma Prior to Second-Look Surgery [Phase 1]

  Phase 1 clinical trial evaluating intra-arterial chemotherapy for atypical choroid plexus papilloma and choroid plexus carcinoma prior to se…

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors [Phase 1]

  Phase 1 clinical trial evaluating B7-H3–specific CAR T cell therapy delivered locoregionally for diffuse intrinsic pontine glioma/diffuse mi…

• CLINICAL_TRIALS trial_result · 2026-03-25
  Clinical Trial Update: Intra-Arterial Chemotherapy for Newly Diagnosed, Residual, or Recurrent Atypical Choroid Plexus Papilloma and Choroid Plexus Carcinoma Prior to Second-Look Surgery [Phase 1]

  This update notes the termination of a Phase 1 trial evaluating intra-arterial chemotherapy for atypical choroid plexus papilloma and choroi…

• CLINICAL_TRIALS trial_result · 2026-01-14
  Clinical Trial Update: A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors [Phase 1]

  This Phase 1 clinical trial assesses the safety, dosing, and delivery of NEO100 in pediatric brain and CNS tumors and is not yet recruiting.

• CLINICAL_TRIALS research · 2025-12-17
  Clinical Trial Update: HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors [Phase 1]

  Phase 1 trial evaluating locoregional HER2-targeted CAR T-cell therapy for pediatric recurrent or refractory central nervous system tumors a…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2025-12-17
  Clinical Trial Update: EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors [Phase 1]

  Phase 1 trial evaluating locoregional EGFR806-specific CAR T cells for EGFR-positive pediatric CNS tumors. The study status is completed.

• CLINICAL_TRIALS withdrawal · 2024-10-26
  Clinical Trial Update: Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer [Phase 1]

  A Phase 1 trial investigating chemotherapy and donor stem cell transplantation for high-grade brain cancers has been withdrawn. The study in…

• CLINICAL_TRIALS trial_result · 2019-01-30
  Clinical Trial Update: Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma [Phase 2]

  Phase 2 trial update on risk-adapted therapy for young children with embryonal brain tumors, choroid plexus carcinoma, high-grade glioma, or…